Artificial Intelligence May Evolve as a Clinical Decision-Making Tool
Bruce Feinberg, DO, VP, Chief Medical Officer, Cardinal Health Specialty Solutions comments on how artificial intelligence may evolve into a necessary decision-making tool for physicians.
News
Honoring Dr. Krystal Cascetta, Devoted Cancer Researcher
1,140 Views
Nivolumab and Pembrolizumab Dosing Intervals Optimizing Cancer Treatment
97 Views
Cancer Drug Research: Expanded Phase 1 Program to the Dallas Area Anthony Tolcher MD
204 Views
Martin S. Tallman, MD @MartinTallman @sloan_kettering @WeillCornell #ASHPresident21 #ASH #Cancer #Research Begins Ter...
22 Views
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic ...
Study Findings: DNA that Pinpoint Risks for Cancers - Benjamin Tycko, MD @HMHNewJersey
Classical Cancer Epigenetic vs Epigenetic Mapping - Benjamin Tycko, MD @HMHNewJersey
Signposts in DNA that Pinpoint Risks for Cancers and other Diseases - Benjamin Tycko, MD @HMHNewJersey
J. Marie Suga MD on Benefits in Implementing a Genomic Oncology Program #ASCO2020 #ASCO @jmsuga
J. Marie Suga MD on Implementing a Genomic Oncology Program: What Are The Barriers? #ASCO2020 #ASCO @jmsuga
J. Marie Suga MD on Implementing a Genomic Oncology Program #ASCO2020 #ASCO @jmsuga
Oncocyte announces launch of CLIA-Validated DetermaIO™